Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Collegium Pharmaceutical Inc., 3 years.
Collegium Pharmaceutical Inc.
Director
Karyopharm Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 2025 | Collegium Pharmaceutical Inc. | Grant or award | +9,791 | — | — |
| May 16, 2024 | Collegium Pharmaceutical Inc. | Grant or award | +7,693 | — | — |
| May 14, 2024 | Collegium Pharmaceutical Inc. | Option exercise | +28,985 | $5.73 | $166,084 |
| May 14, 2024 | Collegium Pharmaceutical Inc. | Open-market sale | −28,985 | $32.30 | $936,216 |
| Sep 12, 2023 | Karyopharm Therapeutics Inc. | Open-market purchase | +41,140 | $1.22 | $50,191 |
| May 18, 2023 | Collegium Pharmaceutical Inc. | Grant or award | +9,792 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.